Understanding processing-induced phase transformations in erythromycin–PEG 6000 solid dispersions
- 1 August 2006
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 95 (8), 1723-1732
- https://doi.org/10.1002/jps.20640
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Phase transformation considerations during process development and manufacture of solid oral dosage formsAdvanced Drug Delivery Reviews, 2004
- Effects of Excipients on Hydrate Formation in Wet Masses Containing TheophyllineJournal of Pharmaceutical Sciences, 2003
- Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepineInternational Journal of Pharmaceutics, 2002
- The influence of impurities and solvents on crystallizationPublished by Elsevier BV ,2002
- Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processesAdvanced Drug Delivery Reviews, 2001
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 2001
- Improving drug solubility for oral delivery using solid dispersionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Solid dispersion of poorly water‐soluble drugs: Early promises, subsequent problems, and recent breakthroughsJournal of Pharmaceutical Sciences, 1999
- Influence of polyethylene glycol 4000 on the polymorphic forms of diflunisalEuropean Journal of Pharmaceutical Sciences, 1999
- Pharmaceutical Applications of Solid Dispersion SystemsJournal of Pharmaceutical Sciences, 1971